X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18112) 18112
Publication (1843) 1843
Newsletter (703) 703
Newspaper Article (465) 465
Book Review (422) 422
Magazine Article (262) 262
Book / eBook (214) 214
Book Chapter (170) 170
Dissertation (136) 136
Trade Publication Article (95) 95
Transcript (34) 34
Conference Proceeding (24) 24
Web Resource (10) 10
Data Set (8) 8
Reference (7) 7
Report (4) 4
Government Document (2) 2
Paper (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15152) 15152
hiv infections - drug therapy (10599) 10599
hiv (7793) 7793
male (7015) 7015
index medicus (6977) 6977
female (6771) 6771
anti-hiv agents - therapeutic use (6192) 6192
adult (6091) 6091
infectious diseases (5747) 5747
hiv protease inhibitors - therapeutic use (4600) 4600
human immunodeficiency virus--hiv (4429) 4429
middle aged (4053) 4053
aids (3719) 3719
protease inhibitors (3613) 3613
antiretroviral therapy (3610) 3610
immunology (3534) 3534
hiv infections - virology (3525) 3525
drug therapy (3421) 3421
hiv infection (3336) 3336
virology (3214) 3214
viral load (3074) 3074
drug therapy, combination (3051) 3051
antiviral agents (2976) 2976
pharmacology & pharmacy (2821) 2821
research (2754) 2754
hiv-1 - drug effects (2627) 2627
health aspects (2605) 2605
reverse transcriptase inhibitors - therapeutic use (2471) 2471
cd4 lymphocyte count (2440) 2440
highly active antiretroviral therapy (2381) 2381
human-immunodeficiency-virus (2348) 2348
antiretroviral drugs (2326) 2326
human immunodeficiency virus (2195) 2195
treatment outcome (2137) 2137
antiretroviral therapy, highly active (2077) 2077
acquired immune deficiency syndrome--aids (2019) 2019
hiv-1 - genetics (2018) 2018
hiv infections - complications (1989) 1989
microbiology (1958) 1958
therapy (1824) 1824
research article (1804) 1804
risk factors (1796) 1796
infection (1788) 1788
hiv-1 (1786) 1786
care and treatment (1725) 1725
hiv infections - immunology (1725) 1725
medicine (1706) 1706
drug resistance (1583) 1583
infections (1508) 1508
ritonavir - therapeutic use (1496) 1496
anti-hiv agents - adverse effects (1460) 1460
mutation (1455) 1455
viruses (1438) 1438
active antiretroviral therapy (1434) 1434
hiv patients (1434) 1434
virus diseases (1408) 1408
hiv protease inhibitors - adverse effects (1358) 1358
animals (1337) 1337
anti-hiv agents - pharmacology (1297) 1297
acquired immune deficiency syndrome (1273) 1273
adolescent (1260) 1260
anti-hiv agents - administration & dosage (1255) 1255
multidisciplinary sciences (1236) 1236
ritonavir (1193) 1193
science (1187) 1187
analysis (1159) 1159
anti-retroviral agents - therapeutic use (1157) 1157
cohort studies (1104) 1104
rna, viral - blood (1088) 1088
hiv protease inhibitors - administration & dosage (1083) 1083
immunodeficiency-virus type-1 (1072) 1072
drug resistance, viral (1070) 1070
drug interactions (1054) 1054
aged (1053) 1053
hiv infections - epidemiology (1048) 1048
genotype (1037) 1037
proteases (1037) 1037
medicine, general & internal (1014) 1014
aids/hiv (1008) 1008
retrospective studies (1006) 1006
dosage and administration (1004) 1004
proteins (965) 965
patients (945) 945
child (939) 939
mortality (932) 932
prospective studies (932) 932
medical research (923) 923
young adult (918) 918
hiv-1 - physiology (913) 913
acquired immunodeficiency syndrome - drug therapy (912) 912
hiv protease inhibitors - pharmacology (902) 902
antiretroviral agents (898) 898
prevalence (894) 894
antiviral agents - therapeutic use (890) 890
pharmacokinetics (888) 888
article (887) 887
hiv-infected patients (884) 884
anti-hiv agents (878) 878
physiological aspects (876) 876
hiv infections - blood (865) 865
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (150) 150
Collection Dvlpm't (Acquisitions) - Closed Orders (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (20) 20
UofT at Mississauga - Stacks (13) 13
UofT at Scarborough - Stacks (13) 13
Online Resources - Online (9) 9
New College (Ivey) - Stacks (7) 7
Robarts - Stacks (6) 6
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Toronto East General Hospital - Stacks (4) 4
Credit Valley Hospital - Stacks (3) 3
Gerstein Science - Reference (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
St. Michael's Hospital - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Gerstein Science - Missing (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
University College (Laidlaw) - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Law (Bora Laskin) - Theses (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Reserve desk (1) 1
Providence Healthcare - Stacks (1) 1
Regis College - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Augustine's Seminary - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19476) 19476
Spanish (263) 263
French (154) 154
German (116) 116
Japanese (25) 25
Italian (21) 21
Portuguese (20) 20
Russian (18) 18
Dutch (15) 15
Chinese (14) 14
Polish (9) 9
Danish (7) 7
Korean (4) 4
Turkish (4) 4
Norwegian (3) 3
Hebrew (2) 2
Hungarian (2) 2
Serbian (2) 2
Catalan (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 10/2014, Volume 161, Issue 7, pp. 461 - 471
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 6, pp. 2047 - 2055
Background & Aims Therapeutic regimens are being developed for patients with hepatitis C virus (HCV) infection that do not include the combination of... 
Gastroenterology and Hepatology | Drug | Peginterferon-Free | Direct-Acting Antivirals | Clinical Trial | ANTIVIRAL AGENTS | VIROLOGICAL RESPONSE SVR | CHRONIC HEPATITIS-C | IN-VITRO | THERAPY | PEGINTERFERON ALPHA-2A | COMBINATION TREATMENT | RESISTANCE | GENOTYPE 1 INFECTION | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Acrylates - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA Replicase - antagonists & inhibitors | RNA, Viral - blood | Thiazoles - therapeutic use | Oligopeptides - adverse effects | Thiazoles - adverse effects | Viral Load | Acrylates - adverse effects | Oligopeptides - therapeutic use | Protease Inhibitors - adverse effects | Female | Benzimidazoles - adverse effects | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | RNA, Viral - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Complications and side effects | Antiviral agents | Care and treatment | Protease inhibitors | Proteases | Universities and colleges | Hepatitis C | Hepatitis C virus | Ribavirin | Anti-HIV agents
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 7, pp. 630 - 639
Journal Article
Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 5, pp. 1767 - 1777
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Summary Background Problems associated with lifelong antiretroviral therapy, such as need for strict adherence, drug-related toxic effects, difficulties with... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | EFFICACY | SAFETY | NAIVE HIV-1-INFECTED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | INFECTED PATIENTS | PROTEASE INHIBITORS | TENOFOVIR | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 1, pp. 27 - 35
Summary Background Elvitegravir is a once daily inhibitor of HIV-1 integrase boosted by ritonavir. We aimed to compare the efficacy and safety of elvitegravir... 
Infectious Disease | INFECTIOUS DISEASES | DARUNAVIR-RITONAVIR | TREATMENT-NAIVE | DOSE-RESPONSE | COMBINATION THERAPY | TMC125 ETRAVIRINE | HIV-1-INFECTED PATIENTS | INFECTION | PLACEBO-CONTROLLED TRIAL | INTEGRASE INHIBITOR | SUBGROUP | Humans | Middle Aged | Male | RNA, Viral - blood | Alanine Transaminase - blood | Diarrhea - chemically induced | Viral Load | Oligopeptides - therapeutic use | Pyrrolidinones - administration & dosage | HIV Infections - immunology | Drug Therapy, Combination - adverse effects | Quinolones - adverse effects | Quinolones - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Female | Raltegravir Potassium | Pyridines - therapeutic use | Anti-Retroviral Agents - therapeutic use | Pyrrolidinones - adverse effects | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Pyrrolidinones - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | HIV-1 - immunology | Quinolones - administration & dosage | Aspartate Aminotransferases - blood | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Lopinavir - therapeutic use | Antiviral agents | Medical research | Protease inhibitors | Proteases | Medicine, Experimental | HIV patients | HIV (Viruses) | Anti-HIV agents
Journal Article